Cediranib
288383-20-0
99%
/
exporting package
2024-10-29
Drospirenone,Tretinoin,Tranexamic acid,Desogestrel,Diosmin,Isotretinoin
-
Product Description
-
Seller Information
-
DescriptionKeywords
Cediranib
antineoplastic
Cediranib factory
Quick Details
ProName:Cediranib
CasNo:288383-20-0
Molecular Formula:C25H27FN4O3
Appearance:White Powder
Application:antineoplastic
DeliveryTime:prompt
PackAge:exporting package
Port:main ports in China
ProductionCapacity:10 Kilogram/Week
Purity:99%
Storage:cool and dry place
Transportation:by sea, by air,by courier
Basic Info-
Product Name:
Cediranib
Other Name:Quinazoline,4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-;4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]quinazoline;4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline;AZD 2171;Cediranib;ZD 2171;4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline;AZD2171;AZD-2171;790713-41-6;557795-03-6
CAS No.:288383-20-0
Molecular Formula:C25H27FN4O3
InChIKeys:InChIKey=XXJWYDDUDKYVKI-UHFFFAOYSA-N
Molecular Weight:450.51
Exact Mass:450.51
EC Number:1308068-626-2
UNII:NQU9IPY4K9
DSSTox ID:DTXSID10183035
ATC Code:L - Antineoplastic and immunomodulating agents
Categories:
Characteristics-
PSA:
72.5
XLogP3:4.9
Density:1.3±0.1 g/cm3
Boiling Point:626.557°C at 760 mmHg
Flash Point:332.7±31.5 °C
Refractive Index:1.642
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 3, Oral
Reproductive toxicity, Category 2
Specific target organ toxicity â repeated exposure, Category 1
Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H301 Toxic if swallowed
H361 Suspected of damaging fertility or the unborn child
H372 Causes damage to organs through prolonged or repeated exposure
H410 Very toxic to aquatic life with long lasting effects
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P273 Avoid release to the environment.
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
P318 IF exposed or concerned, get medical advice.
P319 Get medical help if you feel unwell.
P391 Collect spillage.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Drospirenone,Tretinoin,Tranexamic acid,Desogestrel,Diosmin,Isotretinoin
-
Location:
1115JINGUI MANSION, GUDUN RD, HANGZHOU, CHINA
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
15
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
51-100
-
Year of Establishment:
2005
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product